A prospective evaluation of the influence of three bariatric procedures on insulin resistance improvement. Should the extent of undiluted bile transit be considered a key postoperative factor altering glucose metabolism?

Wideochirurgia I Inne Techniki Maloinwazyjne

Volumn 10, Issue 2, 2015, Pages 213-228

  Kaska, Łukasz ^a   Proczko, Monika ^a   Wis̈niewski, Piotr ^a   Stankiewicz, Marta ^a   Gill, Derek ^a   ͆ledziński, Zbigniew ^a  

^a MEDICAL UNIVERSITY OF GDANSK   (Poland)

Author keywords

Homeostasis model assessment for insulin resistance; Insulin resistance; One anastomosis gastric bypass; Role of bile; Roux en Y gastric bypass; Sleeve gastrectomy; Type 2 diabetes mellitus

Indexed keywords

GLUCOSE;

ADULT; ARTICLE; BARIATRIC SURGERY; BILE FLOW; BILE REFLUX; CONSTIPATION; CYANOCOBALAMIN DEFICIENCY; DIARRHEA; DUODENO JEJUNAL EXCLUSION; FEMALE; GASTRITIS; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; HUMAN; HYPOALBUMINEMIA; HYPOGLYCEMIA; ILEITIS; INSULIN RESISTANCE; INSULIN SENSITIVITY; INTERMETHOD COMPARISON; IRON DEFICIENCY ANEMIA; LAPAROSCOPIC SLEEVE GASTRECTOMY; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; MORBID OBESITY; ONE ANASTOMOSIS GASTRIC BYPASS; POSTOPERATIVE HEMORRHAGE; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PROSPECTIVE STUDY; REOPERATION; ROUX EN Y GASTRIC BYPASS; SURGICAL TECHNIQUE; TREATMENT RESPONSE; ULCER; VITAMIN D DEFICIENCY; VOMITING;

EID: 84936763381     PISSN: 18954588     EISSN: 22990054     Source Type: Journal    
DOI: 10.5114/wiitm.2015.52062     Document Type: Article

References (69)

1. Zimmet P. The burden of type 2 diabetes: are we doing enough? Diabetes Metab 2003; 29: 6S9-18.
2. Stratton IM. Association of glycemia with micro and macrovascular complications of type 2 diabetes prospective observational study. BMJ 2000; 321: 405-12.
3. Defronzo RA. Pathogenesis of type 2 diabetes mellitus. Med Clin North Am 2004; 88: 787-835.
4. Gastaldelli A, Ferrannini E, Miyazaki Y, et al. Beta-cell dysfunction and glucose intolerance: results from San Antonio metabolizm study. Diabetologia 2004; 47: 31-9.
5. Wing RR, Blair EH, Bononi P, et al. Caloric restriction per se is a significant factor in improvements in glycemic control and insulin sensitivity during weight loss in obese NIDDM patients. Diabetes Care 1994; 17: 130-6.
6. Weiss EP, Racette SB, Villareal DT, et al. Improvements in glucose tolerance and insulin action induced by increasing energy expenditure or decreasing energy intake: a randomized controlled trial. Am J Clin Nutr 2006; 84: 1033-42.
7. Kelley DE, Wing R, Buonocore C, et al. Relative effects of calorie restriction and weight loss in noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab 1993; 77: 1287-93.
8. Larson-Meyer DE, Heilbronn LK, Redman LM, et al. Effect of calorie restriction with or without exercise on insulin sensitivity, beta-cell function, fat cell size, and ectopic lipid in overweight subjects. Diabetes Care 2006; 29: 1337-44.
9. Unger RH. Minireview: weapons of lean body mass destruction: the role of ectopic lipids in the metabolic syndrome. Endocrinology 2003; 144: 5159-65.
10. Halperin F, Ding SA, Simonson DC, et al. Roux-en-Y gastric bypass surgery or lifestyle with intensive medical management in patients with type 2 diabetes: feasibility and 1-year results of a randomized clinical trial. JAMA Surg 2014; 149: 716-26.
11. Sjostrom L, Lindross AK, Peltonen M, et al.; Swedish Obese Subject Study Scientific Group. Lifestyle, diabetes and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med 2004; 351: 2683-93.
12. Lehmann A, Bobowicz M, Lech P, et al. Comparison of percentage excess weight loss after laparoscopic sleeve gastrectomy and laparoscopic adjustable gastric banding. Videosurgery Miniinv 2014; 9: 351-6.
13. Schauer PR, Kashyap SR, Wolski K, et al. Bariatric surgery versus intensive medical therapy in obese patients with diabetes. NEJM 2012; 366: 1567-76.
14. Meneghini LF. Impact of bariatric surgery on type 2 diabetes. Cell Biochem Biophys 2007; 48: 97-102.
15. Adams TD, Gress RE, Smith SC, et al. Long term mortality after gastric by-pass surgery. N Engl J Med 2007; 357: 753-61.
16. Scopinaro N, Marinari GM, Camerini GB, et al. Specific effects of BPD on the major components of metabolic syndrom: a long term follow-up study. Diabetes Care 2005; 28: 2406-11.
17. Paluszkiewicz R, Kalinowski P, Wróblewski T, et al. Prospective randomized clinical trial of laparoscopic sleeve gastrectomy versus open Roux-en-Y gastrin bypass for the management of patients with morbid obesity. Videosurgery Miniinv 2012; 7: 225-32.
18. Karcz WK, Kuesters S, Marjanovic G, et al. Duodeno-enteral omega switches - more physiological techniques in metabolic surgery. Videosurgery Miniinv 2013; 8: 273-9.
19. Thaler JP, Cummings DE. Minireview: hormonal and metabolic mechanisms of diabetes remission after gastrointestinal surgery. Endocrinology 2009; 150: 2518-25.
20. Nannipieri M, Baldi S, Mari A, et al. Roux-en-Y gastric bypass and sleeve gastrectomy: mechanisms of diabetes remission and role of gut hormones. J Clin Endocrinol Metab 2013; 98: 4391-9.
21. Kotronen A, Juurinen I, Tikkainen M, et al. Increased liver fat, impaired insulin clearance, hepatic and adipose tissue insulin resistance in T2DM. Gastroenterology 2008; 135: 122-30.
22. Kaska L, Mika A, Stepnowski P, et al. The relationship between specific fatty acids of serum lipids and serum high sensitivity C-reactive protein level in morbidly obese women. Cell Physiol Biochem 2014; 34: 1101-8.
23. Salinari S, Bertuzzi A, Asnaghi S, et al. First-phase insulin secretion restoration and differentia response to glucose load depending on the route of the administration in T2DM subjects after bariatric burgery. Diabetes Care 2009; 32: 375-80.
24. Bikman BT, Zheng D, Pories WJ, et al. Mechanism for improved insulin sensivity after gastric bypass surgery. J Clin Endocrinol Metab 2008; 93: 4656-63.
25. Laferrere B, Heshka S, Wang K, et al. Incretin levels and effect are markedly enhanced 1 month after RYGB surgery in obese patients with T2DM. Diabetes Care 2007; 30: 1709-16.
26. Cho YM. A gut feeling to cure diabetes: potential mechanisms of diabetes remission after bariatric surgery. Diabetes Metab J 2014; 38: 406-15.
27. Faria G, Preto J, Lima da Costa E, et al. Acute improvement in insulin resistance after laparoscopic Roux-en-Y gastric bypass: is 3 days enough to correct insulin metabolism? Obesity Surg 2013; 23: 103-10.
28. Laferr?re B. Diabetes remission after bariatric surgery: is it just the incretins? Int J Obes (Lond) 2011; 35 Suppl 3: S22-5.
29. Cohen RV, Pinheiro JC, Schiavo CA, et al. Effects of gastric bypass surgery in patients with type 2 diabetes and only mild obesity. Diabetes Care 2012; 35: 1420-8.
30. Laferrere B. Do we really know why diabetes remits after gastric bypass surgery? Endocrine 2011; 40: 162-7.
31. Camastra S, Gastaldelli A, Mari A. Early and longer term effects of gastric bypass surgery on tissue-specific insulin sensitivity and beta-cell function in morbidly obese patients with and without T2DM. Diabetologia 2011; 54: 2093-102.
32. Pournaras DJ, Glicksman C, Vincent RP. The role of bile after Roux-en-Y gastric bypass in promoting weight loss and improving glycaemic control. Endocrinology 2012; 153: 3613-9.
33. Mingrone G, Castagneto-Gissey L. Mechanisms of early improvement/ resolution of type 2 diabetes after bariatric surgery. Diabetes Metab 2009; 35: 518-23.
34. Mingrone G, Panunzi S, De Gaetano A, et al. Bariatric surgery versus conventional medical therapy for type 2 diabetes. N Engl J Med 2012; 366: 1577-85.
35. Scopinaro N, Adami GF, Papadia FS, et al. Effects of biliopanceratic diversion on type 2 diabetes in patients with BMI 25 to 35. Ann Surg 2011; 253: 699-703.
36. Victorzon M. Single-anastomosis gastric bypass: better, faster, and safer? Scand J Surg 2015; 104: 48-53.
37. Garc?a-Caballero M, Valle M, Mart?nez-Moreno JM. Resolution of diabetes mellitus and metabolic syndrome in normal weight 24-29 BMI patients with one anastomosis gastric bypass. Nutr Hosp 2012; 27: 623-31.
38. Rutledge R. The mini-gastric bypass: experience with the first 1,274 cases obesity. Surgery 2001; 11: 276-80.
39. Lee WJ, Ser KH, Lee YC, et al. Laparoscopic Roux-en-Y vs. mini-gastric bypass for the treatment of morbid obesity: a 10-year experience. Obes Surg 2012; 22: 1827-34.
40. Wallace TM, Levy JC, Matthews DR. Use and abuse of HOMA modeling. Diabetes Care 2004; 27: 1487-95.
41. Fried M, Yumuk V, Oppert JM, et al. Interdisciplinary European guidelines on metabolic and bariatric surgery. Obes Facts 2013; 6: 449-68.
42. Kaska L, Proczko M, Stefaniak TJ, et al. Redesigning the process of laparoscopic sleeve gastrectomy based on risk analysis resulted in 100 consecutive procedures without complications. Videosurgery Miniinv 2013; 8: 289-300.
43. Olbers T, Olsén MF, Maleckas A, Lönroth H. Randomized clinical trial of laparoscopic Roux-en-Y gastric bypass versus laparoscopic vertical banded gastroplasty for obesity. Br J Surg 2005; 92: 557-62.
44. www.thebloodcode.com/homa-ir-calculator
45. Lebovitz H. Type 2 diabetes mellitus - current therapies and the emergence of surgical options. Nature Rev Endocrinol 2011; 7: 408-19.
46. Gil H, Dolores M, Alarcón P, et al. Surgical treatment of type 2 diabetes. Pharmacol Pharmacy 2014; 5; 24.
47. Cummings DE. Endocrine mechanisms mediating remission of diabetes after gastric bypass surgery. Int J Obes 2009; 33: S33-40.
48. Rubino F, Forgione A, Cummings DE, et al. The mechanism of diabetes control after gastrointestinal bypass reveals a role of proximal small intestine in the pathophysiology of T2DM. Ann Surg 2006; 244: 741-9.
49. Gale EAM. GLP-1-based therapies and the exocrine pancreas: more light, or just more heat? Diabetes 2012 61; 986-8.
50. Vetter ML, Wadden TA, Teff KL, et al. GLP-1 plays a limited role in improved glycemia shortly after Roux-en-Y gastric bypass: a comparison with intensive lifestyle modification. Diabetes 2015; 64: 434-46.
51. Roslin MS, Dudiy Y, Brownlee A, et al. Response to glucose tolerance testing and solid high carbohydrate challenge: comparison between Roux-en-Y gastric bypass, vertical sleeve gastrectomy, and duodenal switch. Surg Endosc 2014; 28: 91-9.
52. Paranjape SA, Chan O, Zhu W, et al. Improvement in hepatic insulin sensitivity after Roux-en-Y gastric bypass in a rat model of obesity is partially mediated via hypothalamic insulin action. Diabetologia 2013; 56: 2055-8.
53. Kashyap SR, Daud S, Kelly KR, et al. Acute effects of gastric bypass vs gastric restrictive surgery on beta-cell function and insulinotropic hormones in severely obese patients with T2DM. Inter J Obes 2010; 34: 462-71.
54. Lingvay I, Guth E, Islam A, Livingston E. Rapid improvement in diabetes after gastric bypass surgery: is it the diet or surgery? Diabetes Care 2013; 36: 2741-7.
55. Chambers AP, Jessen L, Ryan KK, et al. Weight-independent changes in blood glucose homeostasis after gastric bypass or vertical sleeve gastrectomy in rats. Gastroenterology 2011; 141: 950-8.
56. Bradley D, Magkos F, Eagon JC, et al. Matched weight loss induced by sleeve gastrectomy or gastric bypass similarly improves metabolic function in obese subjects. Obesity (Silver Spring) 2014; 22: 2026-31.
57. Rubino F, Marescaux J. Effect of duodenal-jejunal exclusion in a non-obese animal model of type 2 diabetes: a new perspective for an old disease. Ann Surg 2004; 239: 1-11.
58. Kamvissi V, Salerno A, Bornstein SR, et al. Incretins or anti-incretins? A new model for the "entero-pancreatic axis". Horm Metab Res 2015; 47: 84-7.
59. Patriti A, Facchiano E, Sanna A, et al. The enteroinsular axis and the recovery from type 2 diabetes after bariatric surgery. Obes Surg 2004; 14: 840-8.
60. Bojsen-M?ller KN, Dirksen C, J?rgensen NB, et al. Early enhancements of hepatic and later of peripheral insulin sensitivity combined with increased postprandial insulin secretion contribute to improved glycemic control after Roux-en-Y gastric bypass. Diabetes 2014; 63: 1725-37.
61. Pinheiro JS, Schiavon CA, Pereira PB, et al. Long-long limb Rouxen-Y gastric bypass is more efficacious in treatment of type 2 diabetes and lipid disorders in super-obese patients. Surg Obes Relat Dis 2008; 4: 521-7.
62. Nergaard BJ, Leifsson BG, Hedenbro J, Gislason H. Gastric bypass with long alimentary limb or long pancreato-biliary limb - long-term results on weight loss, resolution of co-morbidities and metabolic parameters. Obes Surg 2014; 24: 1595-602.
63. Kaska L, Kobiela J, Proczko M, et al. Does the length of the biliary limb influence medium-term laboratory remission of type 2 diabetes mellitus after Roux-en-Y gastric bypass in morbidly obese patients? Videosurgery Miniinv 2014; 9: 31-9.
64. Scopinaro N. Thirty-five years of biliopancreatic diversion: notes on gastrointestinal physiology to complete the published information useful for a better understanding and clinical use of the operation. Obes Surg 2012; 22: 427-32.
65. Weiner RA, Theodoridou S, Weiner S. Failure of laparoscopic sleeve gastrectomy: further procedure? Obes Facts 2011; 4 Suppl 1: 42-6.
66. Taylor DR, Alaghband-Zadeh J, Cross GF, et al. Urine bile acids relate to glucose control in patients with type 2 diabetes mellitus and a body mass index below 30 kg/m2. PLoS One 2014; 9: e93540.
67. Troy S, Soty M, Ribeiro L, et al. Intestinal gluconeogenesis is a key factor for early metabolic changes after RYGB but not after AGB in mice. Cell Metabol 2008; 8: 201-11.
68. Hayes MT, Foo J, Besic V, et al. Is intestinal gluconeogenesis a key factor in the early changes in glucose homeostasis following gastric bypass? Obes Surg 2011; 21: 759-62.
69. Sweeney TE, Morton JM. Metabolic surgery: action via hormonal milieu changes, changes in bile acids or gut microbiota? A summary of the literature. Best Pract Res Clin Gastroenterol 2014; 28: 727-40.